Related Experiment Video

Updated: Jul 5, 2025

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

8.8K

The Challenge of Anticoagulation in Liver Cirrhosis

Julia Carolin Eichholz1, Heiner Wedemeyer1,2,3,4, Benjamin Maasoumy1,5

  • 1Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.

Visceral Medicine
|January 11, 2024
PubMed

Insights

Anticoagulant therapy can benefit liver cirrhosis patients with bleeding risk. Direct-acting oral anticoagulants show promise, but more research is needed for this patient group.

Area of Science:

  • Hematology
  • Hepatology
  • Pharmacology

Background:

  • Advanced liver diseases significantly alter the hemostatic system.
  • Patients with liver cirrhosis face bleeding risks, leading to caution with anticoagulants.
  • This review addresses challenges and advancements in anticoagulation for cirrhotic patients.

Purpose of the Study:

  • To summarize current challenges, recommendations, and developments in anticoagulation for liver cirrhosis patients.
  • To evaluate the safety and efficacy of different anticoagulant options in this cohort.
  • To highlight the need for further research on novel anticoagulants in liver disease.

Main Methods:

  • Review of existing literature on anticoagulation in liver cirrhosis.
  • Analysis of hemostatic system changes in advanced liver disease.
  • Comparison of anticoagulant options including heparins, vitamin K antagonists, and direct-acting oral anticoagulants.

Main Results:

  • Thrombotic event risk in liver cirrhosis is comparable to or higher than in healthy individuals.
  • Standard laboratory markers are insufficient for assessing thrombosis or hemorrhage risk.
  • Direct-acting oral anticoagulants offer potential advantages over traditional anticoagulants.

Conclusions:

  • Anticoagulation can be beneficial in liver disease patients if indicated and with bleeding prophylaxis.
  • Direct-acting oral anticoagulants represent a promising advancement but require more clinical data.
  • Further prospective trials are essential to establish the role of novel anticoagulants in liver cirrhosis.
Abstract

Keywords:
AnticoagulationBleedingLiver cirrhosisTherapyThrombosis

More Related Videos

Application of Hemostatic Devices in Laparoscopic Hepatectomy04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.2K
Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver12:27

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

2.9K

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
69
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
918
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
549
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
143